Exodus Point Capital Management, LP 89bio, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 459,230 shares of ETNB stock, worth $3.38 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
459,230
Previous 16,985
2603.74%
Holding current value
$3.38 Million
Previous $198,000
1757.58%
% of portfolio
0.03%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$104 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$97.7 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$59.1 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$55.7 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$54.3 Million0.99% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $342M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...